東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Extremophilic cyanobacteria for nove...

Mandal, Sikha.

Linked to FindBook

Google Book

Amazon

博客來

Extremophilic cyanobacteria for novel drug development

Record Type:	Electronic resources : Monograph/item
Title/Author:	Extremophilic cyanobacteria for novel drug development/ by Sikha Mandal, Jnanendra Rath.
Author:	Mandal, Sikha.
other author:	Rath, Jnanendra.
Published:	Cham :Springer International Publishing : : 2015.,
Description:	vii, 92 p. :ill., digital ;24 cm.
[NT 15003449]:	1 Introduction -- 2 Secondary Metabolites of Cyanobacteria and Drug Development -- 3 Glycoconjugates of Cyanobacteria and Potential Drug Development from them -- 4 Anticancer Drug Development from Cyanobacteria -- 5 Issues and Challenges of Drug Development from Cyanobacteria.
Contained By:	Springer eBooks
Subject:	Cyanobacteria - Therapeutic use. -
Online resource:	http://dx.doi.org/10.1007/978-3-319-12009-6
ISBN:	9783319120096 (electronic bk.)

Extremophilic cyanobacteria for novel drug development
Mandal, Sikha.

Extremophilic cyanobacteria for novel drug development[electronic resource] /by Sikha Mandal, Jnanendra Rath. - Cham :Springer International Publishing :2015. - vii, 92 p. :ill., digital ;24 cm. - SpringerBriefs in pharmaceutical science & drug development,1864-8118. - SpringerBriefs in pharmaceutical science & drug development..

1 Introduction -- 2 Secondary Metabolites of Cyanobacteria and Drug Development -- 3 Glycoconjugates of Cyanobacteria and Potential Drug Development from them -- 4 Anticancer Drug Development from Cyanobacteria -- 5 Issues and Challenges of Drug Development from Cyanobacteria.

This volume presents recent developments in the novel drug development and potential of extremophilic cyanobacteria. It discusses how these tiny organism originated, produce oxygen that leads to evolution of life on the earth, how their survival strategies in extreme climatic conditions lead to diverse metabolic pathways, and the opportunity to use them to develop novel drugs. The book is comprised of five chapters, starting with the origin of cyanobacteria, their survival strategies under extreme conditions, and their capabilities to change metabolic activities.The second chapter explores the different metabolic pathways found in cyanobacteria and examines advances in this field and recent techniques like MALDI-TOF imaging and metagenomics tools as well as in silico techniques for rapid screening of secondary metabolites. Further chapters cover the glycomics of cyanobacteria, anticancer drug development, and some issues and challenges of using cyanobacteria to develop drugs. Extremophilic Cyanobacteria For Novel Drug Development provides insight into future perspectives in drug development and is a key resource for students, researchers and professionals in pharmacy, medicinal chemistry, pharmacognosy biotechnology, biology, and academics.

ISBN: 9783319120096 (electronic bk.)

Standard No.: 10.1007/978-3-319-12009-6doiSubjects--Topical Terms:

2132381
Cyanobacteria
--Therapeutic use.

LC Class. No.: QR46.5 / .M36 2015

Dewey Class. No.: 615.32939

Extremophilic cyanobacteria for novel drug development
LDR:02566nmm a2200325 a 4500 001 1993858
003 DE-He213
005 20150724132457.0
006 m d
007 cr nn 008maaau
008 151019s2015 gw s 0 eng d
020 $a 9783319120096 (electronic bk.)
020 $a 9783319120089 (paper)
024 7 $a 10.1007/978-3-319-12009-6 $2 doi
035 $a 978-3-319-12009-6
040 $a GP $c GP
041 0 $a eng
050 4 $a QR46.5 $b .M36 2015
072 7 $a TDCW $2 bicssc
072 7 $a MED072000 $2 bisacsh
082 0 4 $a 615.32939 $2 23
090 $a QR46.5 $b .M271 2015
100 1 $a Mandal, Sikha. $3 2132379
245 1 0 $a Extremophilic cyanobacteria for novel drug development $h [electronic resource] / $c by Sikha Mandal, Jnanendra Rath.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2015.
300 $a vii, 92 p. : $b ill., digital ; $c 24 cm.
490 1 $a SpringerBriefs in pharmaceutical science & drug development, $x 1864-8118
505 0 $a 1 Introduction -- 2 Secondary Metabolites of Cyanobacteria and Drug Development -- 3 Glycoconjugates of Cyanobacteria and Potential Drug Development from them -- 4 Anticancer Drug Development from Cyanobacteria -- 5 Issues and Challenges of Drug Development from Cyanobacteria.
520 $a This volume presents recent developments in the novel drug development and potential of extremophilic cyanobacteria. It discusses how these tiny organism originated, produce oxygen that leads to evolution of life on the earth, how their survival strategies in extreme climatic conditions lead to diverse metabolic pathways, and the opportunity to use them to develop novel drugs. The book is comprised of five chapters, starting with the origin of cyanobacteria, their survival strategies under extreme conditions, and their capabilities to change metabolic activities.The second chapter explores the different metabolic pathways found in cyanobacteria and examines advances in this field and recent techniques like MALDI-TOF imaging and metagenomics tools as well as in silico techniques for rapid screening of secondary metabolites. Further chapters cover the glycomics of cyanobacteria, anticancer drug development, and some issues and challenges of using cyanobacteria to develop drugs. Extremophilic Cyanobacteria For Novel Drug Development provides insight into future perspectives in drug development and is a key resource for students, researchers and professionals in pharmacy, medicinal chemistry, pharmacognosy biotechnology, biology, and academics.
650 0 $a Cyanobacteria $x Therapeutic use. $3 2132381
650 0 $a Drug development. $3 716904
650 0 $a Pharmaceutical microbiology. $3 2132382
650 0 $a Extreme environments $x Microbiology. $3 555210
650 0 $a Microbial metabolites. $3 2111411
650 1 4 $a Biomedicine. $3 890831
650 2 4 $a Pharmaceutical Sciences/Technology. $3 1001579
700 1 $a Rath, Jnanendra. $3 2132380
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
830 0 $a SpringerBriefs in pharmaceutical science & drug development. $3 1565757
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-12009-6
950 $a Medicine (Springer-11650)